Skip to content

PALISADE BIO, INC.: 10-Q filed 2020-11-10

What PALISADE BIO, INC. reported in its quarterly report filed 2020-11-10 (fiscal Q3 2020): 27 published measures, 80 facts as tagged in accession 0001171843-20-007837.

This filing

Form
10-Q (quarterly report)
Filed
2020-11-10
Fiscal period
fiscal Q3 2020
Accession
0001171843-20-007837 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PALISADE BIO, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2020-09-3015,169,547USD
At 2019-12-316,583,889USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2020-09-301,047,074USD
At 2019-12-311,457,896USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2020-09-3014,122,473USD
At 2020-06-3016,234,293USD
At 2020-03-319,977,957USD
At 2019-12-315,125,993USD
At 2019-09-307,042,563USD
At 2019-06-301,962,625USD
At 2019-03-313,271,781USD
At 2018-12-316,049,550USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2020-09-3012,651,728USD
At 2019-12-315,114,917USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-2,321,822USD92
2020-01-01 to 2020-09-30-11,847,981USD274
2020-04-01 to 2020-06-30-1,950,941USD91
2020-01-01 to 2020-03-31-7,575,218USD91
2019-07-01 to 2019-09-30-1,763,134USD92
2019-01-01 to 2019-09-30-6,314,047USD273
2019-04-01 to 2019-06-30-1,436,921USD91
2019-01-01 to 2019-03-31-3,113,992USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2020-01-01 to 2020-09-30-6,830,548USD274
2019-01-01 to 2019-09-30-5,206,748USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2020-01-01 to 2020-09-3014,465,916USD274
2019-01-01 to 2019-09-306,726,232USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2020-09-30-233,823,525USD
At 2019-12-31-221,975,544USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2020-09-3015,040USD
At 2019-12-3141,036USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2020-01-01 to 2020-09-30523,961USD274
2019-01-01 to 2019-09-30761,344USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-2,343,636USD92
2020-01-01 to 2020-09-30-6,281,454USD274
2019-07-01 to 2019-09-30-2,124,175USD92
2019-01-01 to 2019-09-30-6,499,121USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2020-09-3014,991,443USD
At 2019-12-315,646,881USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2020-07-01 to 2020-09-303,586USD92
2020-01-01 to 2020-09-3014,015USD274
2019-07-01 to 2019-09-301,913USD92
2019-01-01 to 2019-09-304,437USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2020-09-301,002,120USD
At 2019-12-311,224,757USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2020-09-308,779USD
At 2019-12-3121,064USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2020-07-01 to 2020-09-302,346,136USD92
2020-01-01 to 2020-09-306,292,474USD274
2019-07-01 to 2019-09-302,126,675USD92
2019-01-01 to 2019-09-306,512,015USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2020-07-01 to 2020-09-30466,014USD92
2020-01-01 to 2020-09-301,608,935USD274
2019-07-01 to 2019-09-30825,486USD92
2019-01-01 to 2019-09-303,294,402USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2020-09-3017,295,703shares
At 2019-12-313,866,457shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2020-09-30247,775,027USD
At 2019-12-31227,067,058USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2020-09-30-3,986USD
At 2019-12-31-6,186USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2020-09-30152,625USD
At 2019-12-31668,936USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-2,318,642USD92
2020-01-01 to 2020-09-30-11,845,781USD274
2019-07-01 to 2019-09-30-1,767,635USD92
2019-01-01 to 2019-09-30-6,321,304USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2020-07-01 to 2020-09-301,880,122USD92
2020-01-01 to 2020-09-304,683,539USD274
2019-07-01 to 2019-09-301,301,189USD92
2019-01-01 to 2019-09-303,217,613USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2019-07-01 to 2019-09-3026,935USD92
2019-01-01 to 2019-09-30-282,371USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2020-07-01 to 2020-09-3021,814USD92
2020-01-01 to 2020-09-30-5,566,527USD274
2019-07-01 to 2019-09-30361,041USD92
2019-01-01 to 2019-09-30185,074USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2020-01-01 to 2020-09-3014,015USD274
2019-01-01 to 2019-09-304,437USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-09-30-12,285USD274
2019-01-01 to 2019-09-30-232,903USD273

Inspect the source

Entity
PALISADE BIO, INC. / CIK 0001357459
Captured
2026-09-20T07:55:46.162Z
SEC response SHA-256
1d4973c07aed8ad894103731546b55683b331acdd472b37e4b33a98a2f63a74c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001357459.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))